ROI Financial Advisors
LLY icon

ROI Financial Advisors’s Eli Lilly LLY Stock Holding History

ROI Financial Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$10.7M Sell
9,214
-306
-3% -$361K 5.54% 5
2026
Q2 		$11.4M Sell
9,520
-328
-3% -$335K 5.91% 5
2026
Q1 		$9.06M Sell
9,848
-205
-2% -$208K 5.42% 5
2025
Q4 		$10.8M Sell
10,053
-552
-5% -$528K 6.2% 4
2025
Q3 		$8.09M Sell
10,605
-696
-6% -$518K 4.83% 5
2025
Q2 		$8.81M Sell
11,301
-382
-3% -$297K 5.6% 4
2025
Q1 		$9.6M Sell
11,683
-287
-2% -$239K 7.01% 1
2024
Q4 		$9.24M Sell
11,970
-1,028
-8% -$851K 6.29% 3
2024
Q3 		$11.5M Sell
12,998
-794
-6% -$714K 7.95% 2
2024
Q2 		$12.5M Sell
13,792
-166
-1% -$133K 9.08% 2
2024
Q1 		$10.9M Sell
13,958
-1,792
-11% -$1.28M 8.54% 1
2023
Q4 		$9.18M Buy
+15,750
New +$9.19M 7.6% 1

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

ROI Financial Advisors's LLY Position: Q3 2026 in Review

ROI Financial Advisors reduced its Eli Lilly (LLY) stake by 3.2% in Q3 2026, selling an estimated $361K and leaving 9,214 shares worth $10.7M. The position accounts for 5.54% of the portfolio, ranked #5.

ROI Financial Advisors first reported a position in LLY in Q4 2023 and has held it in 12 quarters since. The position peaked at $12.5M in Q2 2024. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • ROI Financial Advisors held 9,214 shares of Eli Lilly worth $10.7M as of Q3 2026.
  • ROI Financial Advisors sold 306 Eli Lilly shares in Q3 2026, an estimated $361K.
  • Eli Lilly made up 5.54% of ROI Financial Advisors's portfolio in Q3 2026, its #5 holding.
  • ROI Financial Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 12 quarters since.
  • ROI Financial Advisors's Eli Lilly position peaked at $12.5M in Q2 2024.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on ROI Financial Advisors's 13F filing for Q3 2026, filed 19 Oct 2026.